Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher S Wilcox

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
Journal of the American College of Cardiology|September 11, 2024
Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHFAnkeet S Bhatt, Deepak L Bhatt, Ph Gabriel Steg, et al.
Journal of the American Society of Nephrology : JASN|December 11, 2023
Empagliflozin in Heart Failure: Regional Nephron Sodium Handling EffectsVeena S Rao, Juan B Ivey-Miranda, Zachary L Cox, et al.
Hypertension (Dallas, Tex. : 1979)|October 12, 2020
Acute Kidney Injury Sensitizes the Brain Vasculature to Ang II (Angiotensin II) Constriction via FGFBP1 (Fibroblast Growth Factor Binding Protein 1)Liang Zhao, Xiaoyun Cao, Lingli Li, et al.
The New England Journal of Medicine|November 17, 2020
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart FailureDeepak L Bhatt, Michael Szarek, P Gabriel Steg, et al.
Annals of Internal Medicine|June 21, 2021
Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized TrialMichael Szarek, Deepak L Bhatt, Ph Gabriel Steg, et al.
JACC. Heart Failure|August 9, 2023
Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHFBertram Pitt, Deepak L Bhatt, Michael Szarek, et al.
European Heart Journal|April 22, 2017
Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpointsPatrick Rossignol, Rajiv Agarwal, Bernard Canaud, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
Journal of the American College of Cardiology|September 11, 2024
Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHFAnkeet S Bhatt, Deepak L Bhatt, Ph Gabriel Steg, et al.
Journal of the American Society of Nephrology : JASN|December 11, 2023
Empagliflozin in Heart Failure: Regional Nephron Sodium Handling EffectsVeena S Rao, Juan B Ivey-Miranda, Zachary L Cox, et al.
Hypertension (Dallas, Tex. : 1979)|October 12, 2020
Acute Kidney Injury Sensitizes the Brain Vasculature to Ang II (Angiotensin II) Constriction via FGFBP1 (Fibroblast Growth Factor Binding Protein 1)Liang Zhao, Xiaoyun Cao, Lingli Li, et al.
The New England Journal of Medicine|November 17, 2020
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart FailureDeepak L Bhatt, Michael Szarek, P Gabriel Steg, et al.
Annals of Internal Medicine|June 21, 2021
Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized TrialMichael Szarek, Deepak L Bhatt, Ph Gabriel Steg, et al.
JACC. Heart Failure|August 9, 2023
Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHFBertram Pitt, Deepak L Bhatt, Michael Szarek, et al.
European Heart Journal|April 22, 2017
Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpointsPatrick Rossignol, Rajiv Agarwal, Bernard Canaud, et al.
Pageof 14